Article Versions Notes

Arimura N, Watanabe H, Kato H, Imafuku T, Nakano T, Sueyoshi M, Chikamatsu M, Tokumaru K, Nagasaki T, Maeda H, et al. Advanced Oxidation Protein Products Contribute to Chronic-Kidney-Disease-Induced Adipose Inflammation through Macrophage Activation. Toxins. 2023; 15(3):179. https://doi.org/10.3390/toxins15030179

Arimura, Nanaka, Hiroshi Watanabe, Hiromasa Kato, Tadashi Imafuku, Takehiro Nakano, Miyu Sueyoshi, Mayuko Chikamatsu, Kai Tokumaru, Taisei Nagasaki, Hitoshi Maeda, and et al. 2023. "Advanced Oxidation Protein Products Contribute to Chronic-Kidney-Disease-Induced Adipose Inflammation through Macrophage Activation" Toxins 15, no. 3: 179. https://doi.org/10.3390/toxins15030179

Arimura, N., Watanabe, H., Kato, H., Imafuku, T., Nakano, T., Sueyoshi, M., Chikamatsu, M., Tokumaru, K., Nagasaki, T., Maeda, H., Tanaka, M., Matsushita, K., & Maruyama, T. (2023). Advanced Oxidation Protein Products Contribute to Chronic-Kidney-Disease-Induced Adipose Inflammation through Macrophage Activation. Toxins, 15(3), 179. https://doi.org/10.3390/toxins15030179